New hope for stubborn hip pain: TAME vs PRP showdown
NCT ID NCT07396246
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests two minimally invasive treatments for people with long-lasting hip pain (Greater Trochanteric Pain Syndrome). Participants will receive either a targeted artery treatment (TAME) or a platelet-rich plasma (PRP) injection. The goal is to see which one reduces pain and improves daily function better over a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TROCHANTERIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Unidade Local de Saúde do Alto Ave
RECRUITINGGuimarães, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••